FDA Clearance Tracker · P040013-S012
GEM 21S (GROWTH ENHANCED MATRIX)
Last checked: Nov 20, 2026Latest source record: Sep 3, 2008 (this decision)Source: openFDAMethods & limitations
Decided
Sep 3, 2008
Approved
Time to decision
285 days
Received Nov 23, 2007. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P040013-S012
- Device name
- GEM 21S (GROWTH ENHANCED MATRIX)
- Applicant
- Lynch Biologics, LLC
- Applicant location
- Franklin, TN
- Received
- Nov 23, 2007
- Decided
- Sep 3, 2008
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol - OSB
- Original approval
- P040013
Device type
- Device class
- Class III
- Regulation
- 21 CFR 872.3930
- Specialty
- Dentistry & Oral Surgery
FDA's approval statement
As written in FDA's record.
APPROVAL OF THE POST-APPROVAL STUDY.
Source documents
Other decisions for Lynch Biologics, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.